Invasive Fungal Infections: Clinical Trials

289 trials for Invasive Fungal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

171 completed, 42 unknown, 29 recruiting, 23 terminated. 46 Phase 3, 33 Phase 4, 32 Phase 2, 27 Not applicable, 19 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 346Completed 35, Terminated 7, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 433Completed 17, Unknown 8, Terminated 4, Not yet recruiting 3, Recruiting 1
Phase 232Completed 17, Terminated 6, Unknown 5, Withdrawn 2, Not yet recruiting 1, Recruiting 1
Not applicable27Completed 17, Unknown 4, Terminated 3, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 119Completed 14, Unknown 2, Withdrawn 2, Terminated 1

Follow Invasive Fungal Infections: new trials by email Literature Review of Invasive Fungal Infections trials Research Report on Invasive Fungal Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of Care
Olorofim, Placebo - Coccidioidomycosis, Disseminated Fungal Infection
Phase 2Not yet recruitingF2G Ltd502026-12-012026-09-22
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test
UllCORE BSI Test - Blood Stream Infection, Blood Stream Infections
RecruitingDeepull Diagnostics S.L.15002026-09-212026-10-08
Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial
Caspofungin only within the study, Caspofungin for 3 days within the study, Placebo only within the study - Candidemia, Invasive Candidiasis
Phase 4Not yet recruitingOliver Cornely, MD4202026-09-012026-09-01
mNGS for IFD in Patients With Hematological Malignancies
metagenomic next-generation sequencing - Hematological Malignancies, Invasive Fungal Disease
Not yet recruitingNanfang Hospital, Southern Medical University502026-08-102026-08-13
Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients
Liposomal Amphotericin B, Alternative Systemic Antifungal Therapy - Invasive Fungal Infection, Solid Organ Transplantation
Not yet recruitingSichuan Provincial People's Hospital1202026-07-012026-06-24
Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients
Amphotericin B - Invasive Fungal Disease
Not applicableNot yet recruitingPeking University People's Hospital152026-04-012026-04-30
Study on the Pharmacokinetic Characteristics of Liposomal Amphotericin B in Patients With Invasive Fungal Infections Undergoing Plasma Exchange Therapy
Collection of pharmacokinetic samples to explore the pharmacokinetic characteristics in severe invasive fungal infection patients receive liposomal amphotericin B who undergo plasma exchange therapy. - Invasive Fungal Infections
Not yet recruitingInstitute of Hematology & Blood Diseases Hospital, China102026-03-302026-04-16
Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children
Liposomal Amphotericin B (LAmB) - Thalassemia, Hematopoietic Stem Cell Transplantation
RecruitingHaikou Affiliated Hospital of Central South University Xiangya School of Medicine302026-02-012026-07-24
Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections
Multiplex PCR-Based Rapid Diagnostic Test, Standard Microbiological Diagnostic Methods - Bloodstream Infections, Bacteremia and Sepsis
RecruitingIstanbul Medipol University Hospital3002026-01-012026-02-13
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia
RecruitingAzienda Ospedaliero-Universitaria Careggi4002025-11-132026-07-02
Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China
IPA and non-IPA groups - ICU, Invasive Pulmonary Aspergillosis
CompletedJianfeng Xie5422025-11-012026-01-09
A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis
Patients received the Drug: liposomal amphotericin B(AmBisome) for treatment - Fungal Disease
RecruitingInstitute of Hematology & Blood Diseases Hospital, China382025-09-302026-01-21
Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
Liver Cirrhosis, Viral Pneumonia
Active not recruitingUniversitaire Ziekenhuizen KU Leuven4502025-08-012026-03-04
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
Liposomal Amphotericin B - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
RecruitingHaikou Affiliated Hospital of Central South University Xiangya School of Medicine302025-08-012026-11-20
Immunomonitoring of Mold Invasive Infections
Invasive Fungal Disease, Mold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium
RecruitingAssistance Publique - Hôpitaux de Paris202025-07-282025-11-20
Fungal Status and Prognosis in ABPA
ABPA, Allergic Bronchopulmonary Aspergillosis
RecruitingQianfoshan Hospital1142025-07-012026-07-08
A Randomized Study of a Short Duration Therapy for Candidemia
Standard of Care (SOC), Shortened duration of antifungal therapy - CANDIDEMIA
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris3622025-07-012025-03-05
Human Bioequivalence Study of Liposomal Amphotericin B for Injection
Test product (Liposomal amphotericin B for injection, Sichuan Huiyu Pharmaceutical Co., Ltd.), Reference product (AmBisome®, Astellas Pharma US Inc.) - Invasive Fungal Infections, Neutropenic Fever
Not applicableCompletedSichuan Huiyu Pharmaceutical Co., Ltd582025-05-252026-05-27
Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD( Breakthrough Invasive Fungal Disease) in Patients With Malignant Hematological Diseases
Invasive Fungal Disease
RecruitingInstitute of Hematology & Blood Diseases Hospital, China362025-05-192025-08-22

Showing 20 of 289. Sign in to see all of them.

Narrower conditions

Candidemia (69)  ·  Candidiasis, Invasive (64)  ·  Mycoses (53)  ·  Invasive Pulmonary Aspergillosis (43)  ·  Candidiasis (37)  ·  Fungemia (30)  ·  Aspergillosis (24)  ·  Torulopsis (22)  ·  Hematologic Neoplasms (16)  ·  Sepsis (14)  ·  Neutropenia (13)  ·  Bacteremia (12)  ·  Critical Illness (8)  ·  Leukemia (7)

Broader conditions

Bacterial Infections and Mycoses (289)  ·  Infections (288)  ·  Mycoses (236)  ·  Pathological Conditions, Signs and Symptoms (112)  ·  Pathologic Processes (108)  ·  Inflammation (90)  ·  Systemic Inflammatory Response Syndrome (89)  ·  Candidiasis (80)  ·  Sepsis (77)  ·  Fungemia (61)  ·  Respiratory Tract Diseases (50)  ·  Lung Diseases (49)  ·  Lung Diseases, Fungal (45)  ·  Candidiasis, Invasive (41)

Interventions

Micafungin (32)  ·  Caspofungin (26)  ·  Voriconazole (25)  ·  Fluconazole (20)  ·  Anidulafungin (17)  ·  liposomal amphotericin B (15)  ·  Amphotericin B (12)  ·  Injections (9)  ·  isavuconazole (8)  ·  posaconazole (7)  ·  Blood Specimen Collection (5)  ·  Itraconazole (5)  ·  ibrexafungerp (5)  ·  olorofim (5)  ·  Rezafungin (3)

Sponsors

Pfizer (22)  ·  Astellas Pharma Inc (13)  ·  Merck Sharp & Dohme LLC (10)  ·  Radboud University Medical Center (9)  ·  National Cancer Institute (NCI) (7)  ·  Basilea Pharmaceutica (6)  ·  University Hospital, Lille (6)  ·  Scynexis, Inc. (5)  ·  Universitaire Ziekenhuizen KU Leuven (5)  ·  Asan Medical Center (4)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Astellas Pharma Global Development, Inc. (4)  ·  F2G Ltd (4)  ·  Institute of Hematology & Blood Diseases Hospital, China (4)  ·  Medical University of Graz (4)

Countries

United States (76)  ·  France (50)  ·  China (44)  ·  Italy (32)  ·  Germany (31)  ·  Belgium (28)  ·  Spain (28)  ·  Netherlands (25)  ·  Canada (20)  ·  South Korea (20)  ·  Israel (16)  ·  United Kingdom (16)  ·  Austria (15)  ·  Australia (14)  ·  Brazil (14)

Top investigators

David Angulo, MD (4)  ·  Marc Engelhardt (4)  ·  Robert Krause, MD (3)  ·  Joost Wauters, MD, PhD (2)  ·  Peter G Pappas, MD (2)  ·  Peter Pappas, MD (2)  ·  Qing Wen (2)  ·  William J Steinbach, MD (2)  ·  Aiming Pang, doctor (1)  ·  Alberto M Borobia, MD, PhD (1)

Results publications

PMID 28459966, PMID 28597967, PMID 33891293, PMID 31280481, PMID 21147825, PMID 23315320, PMID 26969258, PMID 33438477, PMID 37185921, PMID 38008099, PMID 38502709, PMID 39468640, PMID 39529079, PMID 41940006, PMID 10394018, PMID 10394019, PMID 11561801, PMID 12145716, PMID 12729424, PMID 1542320, PMID 16127033, PMID 16436724, PMID 17568028, PMID 17719934, PMID 19473094, PMID 19485785, PMID 19804626, PMID 21565903, PMID 21729932, PMID 21854805, PMID 22018278, PMID 22469884, PMID 22814329, PMID 22879929, PMID 22955439, PMID 23676114, PMID 23710653, PMID 24165173, PMID 24261608, PMID 24550378, PMID 24559321, PMID 24669841, PMID 24906361, PMID 24948702, PMID 25040144, PMID 25097069, PMID 25139840, PMID 25149761, PMID 25203869, PMID 25293517

NIH funding

2008 (4), 2017 (4), 2019 (3), 2009 (2), 2015 (2), 2014 (1), 2018 (1), 2023 (1), KL2TR000136 (1), R01AI139032 (1), R01AI170385 (1), U01CK000692 (1), U10CA095861 (1), UG1CA189955 (1), UM1AI104681 (1)